Skip to main content
. 2017 Nov 14;15(1):813–820. doi: 10.3892/ol.2017.7399

Figure 4.

Figure 4.

Cytotoxicity of cetuximab or cetuximab plus an miR-9 mimic or inhibitor in hepatocellular carcinoma cell lines, (A) Huh7, (B) Hep3B, (C) SNU387 and (D) SNU449, treated with eIF-5A-2 siRNA. miR-9, microRNA-9.